The Relevance of Using 5α-Reductase Inhibitors in the Conservative Management of Benign Prostatic Hyperplasia: A Review
September 2025
in “
Consilium Medicum
”

TLDR 5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.
The review discusses the increasing incidence of benign prostatic hyperplasia (BPH) and its impact on younger populations, highlighting the need for effective treatment strategies. It emphasizes the role of 5α-reductase inhibitors in managing lower urinary tract symptoms (LUTS) associated with BPH. These inhibitors are shown to slow disease progression and prepare patients for surgery, reducing peri- and postoperative risks. Additionally, the article considers the potential of 5α-reductase inhibitors in prostate cancer chemoprevention and treating androgenetic alopecia, indicating their broader therapeutic applications.